Enimed Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Enimed Limited - overview

Established

2007

Location

Pinner, -, UK

Primary Industry

Retail

About

Enimed Limited is an independent pharmacy group delivering essential NHS and private healthcare services, focusing on enhancing patient care through a breadth of offerings and convenient online solutions. Founded in 2007, Enimed Limited operates as an independent pharmacy group providing healthcare services. The company has maintained a stable business model without significant pivots. Headquartered in the UK, it has multiple branches in regions such as Berkshire, Buckinghamshire, Hertfordshire, London, Middlesex, Surrey, Sussex, West Midlands, and West Yorkshire.


The founder's information is not publicly available, and there are no mentions of parent companies or subsidiaries. Enimed Limited operates as an independent pharmacy group, providing a comprehensive range of NHS and private services across multiple branches located in regions including Berkshire, Buckinghamshire, Hertfordshire, London, Middlesex, Surrey, Sussex, West Midlands, and West Yorkshire. The company’s core offerings include the management of NHS and private prescriptions, a travel clinic for vaccinations, and various health advice services. Customers can conveniently order repeat prescriptions online, benefiting from features such as SMS reminders and collection notifications.


Enimed focuses on enhancing patient experience by offering the ability to book appointments for vaccinations or private health services online, catering to individual needs in a friendly pharmacy environment. The target clientele encompasses local residents seeking both routine pharmaceutical care and specialized services such as travel vaccinations, thereby addressing the healthcare needs of diverse populations across its operating regions. Enimed Limited generates revenue primarily through the provision of prescription services, both one-off and repeat, as well as private healthcare consultations and travel vaccinations. The business model includes direct interactions with consumers, where patients can utilize the online prescription manager for seamless ordering and notifications.


Revenue is derived from fees associated with NHS prescriptions, private prescriptions, and travel clinic services, which may include a flat fee for consultations or a charge for each vaccination administered. Each branch operates with a consistent pricing structure that aligns with industry standards for both NHS and private services. The company’s revenue is bolstered by its ability to attract local clientele through its direct-to-consumer approach, fostering community trust and loyalty in its healthcare offerings.


Primary Industry

Retail

Sub Industries

Retail, Drug Stores/Convenience Stores

Website

www.enimed.co.uk

Total Amount Raised

Subscriber access only

Enimed Limited - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Enimed Limited - financials

Fiscal Year EndedJan 31, 2019Mar 31, 2020Mar 31, 2021Mar 31, 2022Mar 31, 2023
Revenue (USD)4,441,46434,555,155---
% Revenue Growth (YoY)-----
EBITDA (USD)735,9743,305,299---
Operating Income (USD)550,4671,654,461---
Operating Margin12.4%4.8%---
% EBITDA Margin16.6%9.6%---
NET Income (USD)341,6241,652,945---
% Net Margin7.7%4.8%---

Enimed Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.